AU7762091A - Detection of minimal residual disease in lymphoid malignancies - Google Patents

Detection of minimal residual disease in lymphoid malignancies

Info

Publication number
AU7762091A
AU7762091A AU77620/91A AU7762091A AU7762091A AU 7762091 A AU7762091 A AU 7762091A AU 77620/91 A AU77620/91 A AU 77620/91A AU 7762091 A AU7762091 A AU 7762091A AU 7762091 A AU7762091 A AU 7762091A
Authority
AU
Australia
Prior art keywords
detection
residual disease
minimal residual
lymphoid malignancies
malignancies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77620/91A
Inventor
Jonathan Ben-Ezra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
City of Hope National Medical Center
Original Assignee
City of Hope National Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US50149690A priority Critical
Priority to US501496 priority
Application filed by City of Hope National Medical Center filed Critical City of Hope National Medical Center
Publication of AU7762091A publication Critical patent/AU7762091A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
AU77620/91A 1990-03-30 1991-03-07 Detection of minimal residual disease in lymphoid malignancies Abandoned AU7762091A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US50149690A true 1990-03-30 1990-03-30
US501496 1990-03-30

Publications (1)

Publication Number Publication Date
AU7762091A true AU7762091A (en) 1991-10-30

Family

ID=23993800

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77620/91A Abandoned AU7762091A (en) 1990-03-30 1991-03-07 Detection of minimal residual disease in lymphoid malignancies

Country Status (2)

Country Link
AU (1) AU7762091A (en)
WO (1) WO1991015600A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605798A (en) * 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
US6974666B1 (en) 1994-10-21 2005-12-13 Appymetric, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
AU4745896A (en) * 1995-01-09 1996-07-31 Ambion, Inc. Methods and compositions for use in cleavage and detection of base pair mismatches in double-stranded nucleic acids
DE69605803D1 (en) * 1995-05-11 2000-01-27 Ulf Landegren Detection of mismatches by cleavage with resolvase on a solid support
US5753439A (en) * 1995-05-19 1998-05-19 Trustees Of Boston University Nucleic acid detection methods
US5888731A (en) * 1995-08-30 1999-03-30 Visible Genetics Inc. Method for identification of mutations using ligation of multiple oligonucleotide probes
US5891629A (en) * 1995-09-28 1999-04-06 Ambion, Inc. Compositions for improving RNase cleavage of base pair mismatches in double-stranded nucleic acids
EP0886681A1 (en) 1996-03-04 1998-12-30 Genetrace Systems, Inc. Methods of screening nucleic acids using mass spectrometry
US5811239A (en) * 1996-05-13 1998-09-22 Frayne Consultants Method for single base-pair DNA sequence variation detection
WO1998023776A1 (en) * 1996-11-29 1998-06-04 Amersham Pharmacia Biotech Uk Ltd. Method for determining tandem repeat sequence length
EP1249705A3 (en) 1996-12-31 2003-11-05 Genometrix Incorporated Multiplexed molecular analysis apparatus and its fabrication method
WO1998042867A1 (en) * 1997-03-21 1998-10-01 Greg Firth Extraction and utilisation of vntr alleles
JP2001517086A (en) * 1997-03-21 2001-10-02 グレッグ・ファース Extraction and use of Vntr allele
AU9190098A (en) * 1997-09-18 1999-04-05 Erasmus Universiteit Rotterdam Detection of minimal residual disease in lymphoid malignancies
US6238869B1 (en) 1997-12-19 2001-05-29 High Throughput Genomics, Inc. High throughput assay system
US6232066B1 (en) 1997-12-19 2001-05-15 Neogen, Inc. High throughput assay system
US20030096232A1 (en) 1997-12-19 2003-05-22 Kris Richard M. High throughput assay system
US6104028A (en) * 1998-05-29 2000-08-15 Genetrace Systems Inc. Volatile matrices for matrix-assisted laser desorption/ionization mass spectrometry
WO2000037684A1 (en) * 1998-12-22 2000-06-29 Kris Richard M High throughput assay system using mass spectrometry
WO2013006195A1 (en) * 2011-07-01 2013-01-10 Htg Molecular Diagnostics, Inc. Methods of detecting gene fusions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195B1 (en) * 1986-01-30 1990-11-27 Cetus Corp

Also Published As

Publication number Publication date
WO1991015600A1 (en) 1991-10-17

Similar Documents

Publication Publication Date Title
AU643575B2 (en) Isoquinoline derivatives
AU656015C (en) Methylen-oxindole derivatives and process for their preparation
GB2243166B (en) Vacuum toilet system
AU640253B2 (en) Pharmaceutical composition for rapid suspension in water
KR183027B1 (en) Pharmaceutical agents
GB2242671B (en) Apparatus for assisting in the attachment of an article
AU644249B2 (en) Alpha-oxoacetamide derivatives
AU652793B2 (en) Peptidyl derivatives
AU666702B2 (en) Morphinan derivative and medicinal use
GB2245970B (en) Particle detection
AU677614B2 (en) Methods of detecting Alzheimer's disease
EG19752A (en) Dialkoxy-pyridinyl-benzimidazole derivatives process for their preparation and their pharmaceutical use
AU614482B3 (en) Receptacle
EP0436213A3 (en) Obstacle detection system
AU2277792A (en) Methylen-oxindole derivatives and process for their preparation
AU7930491A (en) Dipeptide derivatives
PL307951A1 (en) Novel derivatives 1h-indole-3-glyoxylamide and pharmaceutical agent
NZ239476A (en) 3-amidopyrazole derivatives; medicaments and preparation thereof
AU6307590A (en) Biphenylmethane derivative and pharmacological use
AU8332991A (en) Reduction processor
GB9018129D0 (en) Castors
HU913640D0 (en) 4-benzoyl-ixioazole derivatives
EP0440950A3 (en) Halogenallyl-azolyl derivatives
SG86971A1 (en) 2-arylthiazole derivatives and pharmaceutical composition thereof
PL301305A1 (en) Novel pakliaxel derivatives and pharmaceutical agent